Hellevuo K, Hoffman P L, Tabakoff B
Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80262, USA.
J Neurochem. 1996 Jul;67(1):177-85. doi: 10.1046/j.1471-4159.1996.67010177.x.
RNase protection assays were used in a comparative analysis of the quantities of mRNA for five "calcium-sensitive" (types I, III, V, VI, and VIII) adenylyl cyclases and one "calcium-insensitive" (type II) adenylyl cyclase in mouse cerebral cortex, cerebellum, and nucleus accumbens. The mRNA levels for type V adenylyl cyclase were dominant in the nucleus accumbens. Type V adenylyl cyclase mRNA was also found in the cerebral cortex and at low levels in the cerebellum. Type I adenylyl cyclase mRNA was the major form in the cerebellum with 15-50-fold higher levels compared with other adenylyl cyclase mRNAs. Type I adenylyl cyclase mRNA was also the most prominent adenylyl cyclase mRNA in the cerebral cortex, although the mRNA levels of other adenylyl cyclase forms were more comparable to those of the type I enzyme in this brain area. The mRNA levels for adenylyl cyclase types II, III, VI, and VIII were intermediate to low depending on the brain area. Cell membranes from the nucleus accumbens demonstrated adenylyl cyclase activity that was synergistically activated by concomitant addition of GTP and forskolin to assay mixtures, reflecting a characteristic of type V adenylyl cyclase protein. Calcium/calmodulin stimulated adenylyl cyclase activity in membranes from all three brain areas. However, synergistic activation of adenylyl cyclase activity by GTP and calcium/calmodulin was noted only with cortical membranes, and this characteristic may reflect the presence of type VIII adenylyl cyclase mRNA in the cortex. Although mRNA for type VIII adenylyl cyclase was almost equivalent in the cortex and cerebellum, the lack of a synergistic effect of GTP plus calcium/calmodulin on the cerebellar enzyme activity may be a result of the significant dominance of type I adenylyl cyclase mRNA (and protein) in the cerebellum. In general, the mRNA levels for the various adenylyl cyclases were predictive of the regulatory characteristics of adenylyl cyclase activity in membranes of the brain areas studied.
核糖核酸酶保护分析用于对小鼠大脑皮层、小脑和伏隔核中五种“钙敏感型”(I、III、V、VI和VIII型)腺苷酸环化酶以及一种“钙不敏感型”(II型)腺苷酸环化酶的mRNA量进行比较分析。V型腺苷酸环化酶的mRNA水平在伏隔核中占主导地位。在大脑皮层中也发现了V型腺苷酸环化酶mRNA,而在小脑中含量较低。I型腺苷酸环化酶mRNA是小脑中的主要形式,其水平比其他腺苷酸环化酶mRNA高15至50倍。I型腺苷酸环化酶mRNA也是大脑皮层中最突出的腺苷酸环化酶mRNA,尽管在该脑区其他腺苷酸环化酶形式的mRNA水平与I型酶的更为相近。II、III、VI和VIII型腺苷酸环化酶的mRNA水平因脑区而异,处于中等至低水平。伏隔核的细胞膜显示出腺苷酸环化酶活性,当向测定混合物中同时添加GTP和福斯高林时,该活性会协同激活,这反映了V型腺苷酸环化酶蛋白的一个特征。钙/钙调蛋白刺激了所有三个脑区细胞膜中的腺苷酸环化酶活性。然而,仅在皮层细胞膜中观察到GTP和钙/钙调蛋白对腺苷酸环化酶活性的协同激活,这一特征可能反映了皮层中VIII型腺苷酸环化酶mRNA的存在。尽管VIII型腺苷酸环化酶的mRNA在皮层和小脑中几乎相当,但GTP加钙/钙调蛋白对小脑酶活性缺乏协同作用可能是由于I型腺苷酸环化酶mRNA(和蛋白)在小脑中占显著优势。总体而言,各种腺苷酸环化酶的mRNA水平可预测所研究脑区细胞膜中腺苷酸环化酶活性的调节特征。